Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (23)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Marniemi, J.
Right arrow Articles by Sourander, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marniemi, J.
Right arrow Articles by Sourander, L.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1998 Oxford University Press

research-article

Blood vitamins, mineral elements and inflammation markers as risk factors of vascular and non-vascular disease mortality in an elderly population

Jukka Marniemia,, Jorma Järvisalob, Tuula Toikkaa, Ismo Räihäb, Markku Ahotupac and Leif Souranderb

aResearth and Development Centre, Social Insurance Institution Turku
bDepartment of Gerlatrlrs, University of Thrku Finland
cDepartment of Physiology, University of Thrku Finland

Reprint requests: Jukka Marniemi Research and Development Centre, Social Insurance Institution, Peltolantie 3. FIN-20720 Turku, Finland

BACKGROUND: The need for protecting agents agamst degenerative processes of the body has been proposed to be especially high in elderly people. In order to evaluate the prognostic value of various biochemical factors in ageing the associations of blood concentrations of several vitamins, mineral elements and some other suggested risk factors with vascular and non-vascular mortality were studied in an elderly population.

METHODS: A large health survey with complete clinical evaluation was carried out in the City of Turku in 1982–1983. A random sample of 344 community-living elderly individuals aged 65 yeats or older, stratified into four age groups, was studied. During the 13 years follow-up 225 subjects had died. Calcium, magnesium, copper, ceruloplasmin, zinc, selenium, iron, ferritin, transferrin, alpha-tocopherol, retinol, folate, vitamin B12 malondialdehyde, orosomucoid and insulin levels were analysed from the blood specimens. The relations between the compounds measured and relative mortality risks during the 13-year follow-up were analysed by Cox proportional hazards model adjusting for other known risk factors.

RESULTS AND CONCLUSIONS: High concentrations of serum copper, orosomucoid and insulin were associated with increased risk of vascular mortality. The relative risks within the subjects of the highest tertile of serum concentrations were 2.2 for copper, 1.8 for orosomucoid, and 1.8 for insulin when adjusted for many confounding risk factors. Low serum vitamin B12 concentrations appeared to be significantly (P=0.01) associated with increased vascular mortality. The associations were essentially not more significant when adjusted only for age. Contrary to earlier observations concentrations of serum magnesium, selenium, alpha-tocopherol, iron and its binding proteins or plasma and erythrocyte folate were not associated with increased mortality risk when adjusted for confounding risk factors. The authors suggest that in elderly subjects these elements and compounds are at the most weak, and probably non-independent risk factors for vascular mortality.

Keywords Antioxidants, lipid peroxidation, mortality, trace elements, vascular, vitamins

Accepted 24 February 1998


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Nutr.Home page
A. D. Dangour, E. Breeze, R. Clarke, P. S. Shetty, R. Uauy, and A. E. Fletcher
Plasma Homocysteine, but Not Folate or Vitamin B-12, Predicts Mortality in Older People in the United Kingdom
J. Nutr., June 1, 2008; 138(6): 1121 - 1128.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Coll. Nutr.Home page
S. Belbraouet, H. Biaudet, A. Tebi, N. Chau, K. Gray-Donald, and G. Debry
Serum Zinc and Copper Status in Hospitalized vs. Healthy Elderly Subjects
J. Am. Coll. Nutr., December 1, 2007; 26(6): 650 - 654.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
M. E Wright, K. A Lawson, S. J Weinstein, P. Pietinen, P. R Taylor, J. Virtamo, and D. Albanes
Higher baseline serum concentrations of vitamin E are associated with lower total and cause-specific mortality in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study.
Am. J. Clinical Nutrition, November 1, 2006; 84(5): 1200 - 1207.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
G. Flores-Mateo, A. Navas-Acien, R. Pastor-Barriuso, and E. Guallar
Selenium and coronary heart disease: a meta-analysis.
Am. J. Clinical Nutrition, October 1, 2006; 84(4): 762 - 773.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
B. Buijsse, E. J. Feskens, D. Schlettwein-Gsell, M. Ferry, F. J Kok, D. Kromhout, L. C. de Groot, and for the SENECA investigators
Plasma carotene and {alpha}-tocopherol in relation to 10-y all-cause and cause-specific mortality in European elderly: the Survey in Europe on Nutrition and the Elderly, a Concerted Action (SENECA)
Am. J. Clinical Nutrition, October 1, 2005; 82(4): 879 - 886.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
A. E Fletcher, E. Breeze, and P. S Shetty
Antioxidant vitamins and mortality in older persons: findings from the nutrition add-on study to the Medical Research Council Trial of Assessment and Management of Older People in the Community
Am. J. Clinical Nutrition, November 1, 2003; 78(5): 999 - 1010.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
V. A. Ploplis, I. Cornelissen, M. J. Sandoval-Cooper, L. Weeks, F. A. Noria, and F. J. Castellino
Remodeling of the Vessel Wall after Copper-Induced Injury Is Highly Attenuated in Mice with a Total Deficiency of Plasminogen Activator Inhibitor-1
Am. J. Pathol., January 1, 2001; 158(1): 107 - 117.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.